Results

Total Results: 1,117 records

Showing results for "choice".

141. EPC-Pilot-Project-A-Dual-Approach-To-Facilitate-Health-Systems-Uptake-Of-Evidence-Synthesis-Reports-Anxiety-In-Children (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-report-anxiety-children_0.pdf
     October 01, 2018 - the EPC report and asked about what other information they require to make their decisions about choice … clinicians were instructed to ask patients for the issue most important to them when making a treatment choice … The diabetes mellitus medication choice decision aid: a randomized trial.

142. Best Practices for Conducting Economic Evaluations in Health Care: A Systematic Review of Quality Assessment Tools (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/economic-evaluation-tools_research.pdf
     October 01, 2012 - criteria were included in seven to nine of the checklists: description of the target population, choice … The choice of an appropriate checklist should be made with the understanding that quality assessment … However, as with the choice of eligibility criteria relating to quality and design of effectiveness … The choice of rate(s) is justified 25. … The choice of variables for sensitivity analysis is justified 29.

143. Hunt_Panel_1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/hunt_panel_1.pdf
     January 01, 2010 - Hunt_Panel_1 Slide  1: Helping  People  Make  Better Health Care  Choices: Why  Web 2.0? Yvonne Hunt, Ph.D., M.P.H. Cancer Prevention Fellow National Cancer Institute, Bethesda, MD Slide  2: Untitled page from the smokefree.gov Web site. Slide  3…

144. Pbt-Lsr-Draft-Report (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/pbt-lsr-draft-report.pdf
     February 04, 2022 - ) Cannabis Products ..... 23 Summary of Findings for Whole-Plant Cannabis and Mixed (Patient-Choice) … • Evidence on whole-plant cannabis (including patient’s choice of products), low THC to CBD ratio … Key Points for Whole-Plant Cannabis and Mixed (Patient-Choice) Cannabis Products • No new studies … evaluated whole-plant cannabis or mixed (patient-choice) cannabis products … evaluated whole-plant cannabis or mixed (patient-choice) cannabis products.

145. Evidence Summary Comparative Effectiveness Review No. 250: Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/cer-250-cannabis-other-plant-based-treatments-evidence-summary.pdf
     October 01, 2021 - • Evidence on whole-plant cannabis (including patient’s choice of products), low- THC to CBD ratio … CBD THC Synthetic THC THC to CBD Ratio Unclear High High Source Any cannabis product (patient’s choice

146. Evidence Summary Comparative Effectiveness Review No. 250: Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-other-plant-based-treatments-evidence-summary_0.pdf
     October 01, 2021 - • Evidence on whole-plant cannabis (including patient’s choice of products), low- THC to CBD ratio … CBD THC Synthetic THC THC to CBD Ratio Unclear High High Source Any cannabis product (patient’s choice

147. Using Deliberative Methods to Engage the Public: Facilitating a Deliberative Session (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/deliberative-methods-facilitation-slides-text.pdf
     January 11, 2017 - Concerns about loss of patient/doctor authority o How people balance the tension between personal choice

148. Disposition of Comments for Evidence Report #208 Part 5 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/public-reporting-quality-improvement_disposition-comments.pdf
     July 26, 2012 - routinely have publicly reported scores for individual providers, this point about informing consumer choice … emergency or based on a doctor's referral or in a one-hospital region, the consumer isn't making a choice … Additional text has been added explaining that no guidance or prior practice dictated the choice of … Section Comment Response Peer Reviewer 5 Results 1) KQ4: impact on patients: be clear about patient choice … 2) Line 23-34: ‘one reason..’ is unclear how volume and market share is associated with consumer choice

149. Methods Guide for Comparative Effectiveness Reviews - Expanded Guidance on Selected Quantitative Synthesis Topics (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/quantitative-synthesis-expanded-methods_methods.pdf
     March 01, 2013 - 14 percent, 13 percent or 31 percent of 115 meta-analyses of binary outcomes when the measure of choice … Explanation of choice of effect measure Specify what type of outcome data is being combined (e.g … If the study design allows a choice of effect measure then choose the one that best answers the research … question and provide a rationale for that choice. 14 Table 2. … Provide interpretation for the individual and combined study estimates based on the type of data and choice

150. Infantile-Hemangioma Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/infantile-hemangioma_executive.pdf
     January 01, 2016 - Lesion characteristics such as size, location, and type (e.g., superficial, deep) also influence the choice … timolol, while deep lesions are less likely to respond.13 Intralesional steroids may be the drug of choice … discovery of its effects on IH lesions in 2008.17 Prior to this, corticosteroids were the drug of choice … , but propranolol has become the typical choice for initial medical management in children without … Lesion characteristics also influence the choice of specific pharmacologic agents.

151. Methods Research Report - Meta-Analytical Statistical Inferences for Continuous Measure Outcomes as a Function of Effect Size Metric and Other Assumptions (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/statistical-inference_research.pdf
     April 01, 2013 - The current results imply that the choice of effect size metrics, estimators, and sampling variances … Findings relevant to meta-analytic practice (effect size and variance choice) ................30 … If meta-analytic statistics and inferences do depend on choice of unstandardized vs. … Choice of Metric When Meta-Analyzing Continuous Measures Although several statistical methods exist … Findings relevant to meta-analytic practice (effect size and variance choice) Design Type Inferential

152. Management of Uterine Fibroids - Evidence Summary (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/evidence-summary-cer-195-uterine-fibroids-final.pdf
     December 01, 2017 - For these reasons, the evidence is insufficient to inform choice of expectant management over other … information is required as a first step towards using individual characteristics to inform treatment choice … were randomly assigned to the intervention received, provider and patient biases in intervention choice

153. Payer Perspectives on Improving Usability of Effective Health Care Products: Bridging the Gap Between Information Needs and Evidence Translation | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/payer-usability/white-paper
     February 03, 2014 - Payer Perspectives on Improving Usability of Effective Health Care Products: Bridging the Gap Between Information Needs and Evidence Translation White Paper February 3, 2014 Download Main Document PDF 294 KB This report is available in PDF (294 kB) only. People using assistive technology may not be ab…

154. Ch 2-User-Guide-To-Ocer 130129 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/ch_2-user-guide-to-ocer_130129.pdf
     January 01, 2011 - 21 Abstract The choice of study design often has profound consequences for the causal interpretation … The choice of study design often has profound consequences for the causal interpretation of study results … treatments and outcomes of interest, as well as the predictors of outcome risk potentially related to choice … Choice of Comparators Both confounding by indication and confounding by frailty may be strongest and … Therefore, the choice of an appropriate study design is at least as important, if not more important

155. Ch 11-User-Guide-To-Ocer 130129 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/ch_11-user-guide-to-ocer_130129.pdf
     January 03, 2012 - Comparison Groups An important choice in study design is the selection of suitable treatment and … useful to explore these subpopulations to determine if the overall associations persist or if the best choice … Samy Suissa illustrated how the choice of cohort definition can affect effect estimates in his paper … The precise choice of transformation requires knowledge of the distribution of the covariate. … • Does the choice of statistical method influence the directionality or strength of the association

156. Cad-Women-Diagnosis Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cad-women-diagnosis_executive.pdf
     June 01, 2012 - The choice of NIT may differ by clinician preference, availability, or setting (outpatient vs. chest … probability, most clinicians would prefer to have patients undergo one NIT prior to determining a treatment choice … Choice of NIT— and whether to use exercise or pharmacological stress imaging—may be influenced by functional … Noncomparative studies have selection, spectrum, and intervention biases for the following reasons: The choice … The information from these clinical trials could inform how the choice of an NIT modality affects prognosis

157. Test-Performance-Metrics Appendixes (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/test-performance-metrics_appendixes.pdf
     January 01, 2005 - informative tests.3 We note that other, more lenient boundaries for LR+ and LR- can be used3 and that the choice

158. S1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/s1.pdf
     October 01, 2007 - resulting from the adverse drug effects of medications, suboptimal treatment response, inappropriate choice

159. Evaluation and Treatment of Cryptorchidism | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/undescended-testicle/research
     December 11, 2012 - Current Page Topic Timeline May. 10, 2010 Topic Suggestion Sep. 2, 2011 Research Protocol Dec. 11, 2012 Systematic Review Apr. 19, 2013 Disposition of Comments Report Evaluation and Treatment of Cryptorchidism Systematic Review Archived December 11, 2012 Web Version [NLM Site] Download Main Document PDF 2.3 MB …

160. Progestogens-Preterm-Birth Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/progestogens-preterm-birth_executive.pdf
     September 01, 2012 - Unresolved issues about choice of progestogen, optimal route of drug delivery, and other candidate high … Ultimately, providing data to support choice of an optimal form of progestogen, to determine whether